TP53 and gastric cancer: To verify the impact of cisplatin and the pan-HDACi SAHA on gastric cancer cells, we also analyzed the expression of Ki67, p53, and the acetylation of the histone H3 at the lysine 9 position (H3K9), which are markers for cell proliferation, DNA damage, and a target of HDACs, respectively (Figure 5).